- 5 Results
Lowest price: € 2.49, highest price: € 208.60, average price: € 64.97
1
Multiple Risk Factors in Cardiovascular Disease: Vascular and Organ Protection (Medical Science Symposia Series)
Order
at ZVAB.com
€ 2.49
Shipment: € 3.501
OrderSponsored link

Multiple Risk Factors in Cardiovascular Disease: Vascular and Organ Protection (Medical Science Symposia Series) - hardcover

1995, ISBN: 0792335031

[EAN: 9780792335030], Gebraucht, sehr guter Zustand, [SC: 3.5], [PU: Springer], KATEGORIEN / KLINISCHE MEDIZIN NATURWISSENSCHAFTEN & TECHNIK INNERE, 440 Seiten Gepflegtes ehemaliges Bibli… More...

NOT NEW BOOK. Shipping costs: EUR 3.50 getbooks GmbH, Bad Camberg, HE, Germany [55883480] [Rating: 5 (von 5)]
2
Multiple Risk Factors in Cardiovascular Disease: Vascular and Organ Protection (Medical Science Symposia Series)
Order
at AbeBooks.de
€ 2.49
Shipment: € 3.501
OrderSponsored link
Multiple Risk Factors in Cardiovascular Disease: Vascular and Organ Protection (Medical Science Symposia Series) - hardcover

1995, ISBN: 0792335031

[EAN: 9780792335030], Gebraucht, sehr guter Zustand, [PU: Springer], KATEGORIEN / KLINISCHE MEDIZIN NATURWISSENSCHAFTEN & TECHNIK INNERE, 440 Seiten Gepflegtes ehemaliges Bibliotheksexemp… More...

NOT NEW BOOK. Shipping costs: EUR 3.50 getbooks GmbH, Bad Camberg, HE, Germany [55883480] [Rating: 5 (von 5)]
3
Order
at Biblio.co.uk
$ 15.11
(aprox. € 13.89)
Shipment: € 20.231
OrderSponsored link
Antonio M. Gotto Jr., Claude Lenfant, Alberico L. Catapano, Rodolfo Paoletti:
Multiple Risk Factors in Cardiovascular Disease: Vascular and Organ Protection (Medical Science Symposia Series, Volume 8) - hardcover

1995

ISBN: 9780792335030

Kluwer Academic Publishers, 1995. 440 pp., hardcover, ex library, else text and binding clean and tight. - If you are reading this, this item is actually (physically) in our stock and r… More...

Shipping costs: EUR 20.23 Zubal Books
4
Order
at Biblio.co.uk
$ 105.91
(aprox. € 97.38)
Shipment: € 16.771
OrderSponsored link
Gotto Jr., Antonio M. [Editor]; Lenfant, Claude [Editor]; Catapano, Alberico L. [Editor]; Paoletti, Rodolfo [Editor];:
Multiple Risk Factors in Cardiovascular Disease: Vascular and Organ Protection (Medical Science Symposia Series) - hardcover

ISBN: 9780792335030

Springer. Hardcover. New. New. In shrink wrap. Looks like an interesting title!, Springer, 6

Shipping costs: EUR 16.77 GridFreed LLC
5
Multiple Risk Factors in Cardiovascular Disease - A. M. Gotto; Claude Lenfant; Alberico L. Catapano; Rodolfo Paoletti
Order
at lehmanns.de
€ 208.60
Shipment: € 0.001
OrderSponsored link
A. M. Gotto; Claude Lenfant; Alberico L. Catapano; Rodolfo Paoletti:
Multiple Risk Factors in Cardiovascular Disease - hardcover

1995, ISBN: 9780792335030

Vascular and Organ Protection, Buch, Hardcover, [PU: Kluwer Academic Publishers], Kluwer Academic Publishers, 1995

Shipping costs:Lieferbar. (EUR 0.00)

1As some platforms do not transmit shipping conditions to us and these may depend on the country of delivery, the purchase price, the weight and size of the item, a possible membership of the platform, a direct delivery by the platform or via a third-party provider (Marketplace), etc., it is possible that the shipping costs indicated by find-more-books.com / find-more-books.com do not correspond to those of the offering platform.

Bibliographic data of the best matching book

Details of the book

Details of the book - Multiple Risk Factors in Cardiovascular Disease


EAN (ISBN-13): 9780792335030
ISBN (ISBN-10): 0792335031
Hardcover
Publishing year: 1995
Publisher: Kluwer Academic Publishers

Book in our database since 2007-10-30T09:46:42-04:00 (New York)
Detail page last modified on 2023-05-17T02:01:20-04:00 (New York)
ISBN/EAN: 0792335031

ISBN - alternate spelling:
0-7923-3503-1, 978-0-7923-3503-0
Alternate spelling and related search-keywords:
Book author: gotto, paoletti, klüwer, lenfant
Book title: series


Information from Publisher

Author: Antonio M. Gotto Jr.; Claude Lenfant; Alberico L. Catapano; Rodolfo Paoletti
Title: Medical Science Symposia Series; Multiple Risk Factors in Cardiovascular Disease - Vascular and Organ Protection
Publisher: Springer Netherland
440 Pages
Publishing year: 1995-07-31
Weight: 0,967 kg
Language: English
85,55 € (DE)
87,95 € (AT)
106,50 CHF (CH)
Not available (reason unspecified)

BB; GB; Hardcover, Softcover / Medizin/Klinische Fächer; Klinische und Innere Medizin; Verstehen; Research; BC

Preface. I: Multiple Risk Factors in Population. 1. Lipid Risk Factors and the Regression of Atherosclerosis; A. M. Gotto Jr. 2. Multiple Risk Factors: What is Next? M. Higgins, C. Lenfant 3. Multiple Risk Factors in Northern Italy; G. A. Feruglio, D. Vanuzzo, G. Cesana, M. Ferrario on behalf of the MONICA- Friuli and MONICA-Brianza Study Groups. 4. Long-Term Associations between Hemostatic Variables and Ischemic Heart Disease; T. W. Meade. 5. Cardiovascular Gene Therapy: Possibilities and Realities; V. J. Dzau, R. Morishita, G. H. Gibbons. 6. Triglycerides and Coronary Heart Disease: An Update; M. H. Criqui. II: Lipids and Lipoproteins. 7. Factors Controlling Lipoprotein Metabolism; E. Sehayek, S. Eisenberg. 8. Apolipoproteins in the Treatment of Vascular and Nonvascular Disease; C. R. Sirtori. 9. Explorations of Postprandial Lipids in a Case of Homozygous APO B45.2; B. Jacotot, A. Piolot, M. Ayraut-Jarrier, N. Lemort, C. Martin, S. Braschi, F. Yen, B. Bihain. 10. Apolipoprotein E Binding and Hepatic Lipase-Mediated Catabolism Make Alternate Pathways in the Metabolism of Intermediate Lipoprotein Particles: Observation in Patients with Hepatic Lipase Deficiency; A. Yamamoto, Y. Ikeda, Z. Tsutsumi, A. Mori, A. Takagi, M. Tsushima. III: Critical Aspects of Vascular Protection of New Dihydropyridine Calcium Antagonists. 11. New Aspects of the Pharmacology of Dihydropyridine Calcium Antagonists; T. Godfraind, O. Feron, N. Morel, S. Salomone, M. Wibo. 12. Membrane Interaction of Lipophilic Dihydropyridines as New Mechanisms for Vascular Protection; G. Gaviraghi, D. Trist. 13. Mechanisms of Free Radical Oxidations and Vascular Damage: Protective Effect of Dihydropyridines; F. Ursini. 14. Lipophilic Dihydropyridines: New Opportunities for Prevention of Atherosclerosis; R. Paoletti. 15. Clinical Trial Design and Noninvasive Atherosclerosis Endpoints for Studying Lipophilic Dihydropyridines; M. G. Bond, M. Mercuri, R. Arens, F. Gianfrate for the ELSA Collaborative Research Group. IV: N-3 Fatty Acids and Cardiovascular Risk Factors. 16. The Biological Roles of n-e Fatty Acids: Metabolic and Nutritional Aspects; C. Galli. 17. Effect of Supplementation with Moderate Doses of n-3 Fatty Acid Ethyl Esters to Hypertriglyceridemic Patients on Lipid and Hemostatic Variables; E. Tremoli, S. Colli, P. Maderna, S. Eligini, E. Stragliotto, P. Risé, F. Pazzucconi, C. R. Sirtori, C. Galli. 18. Long-Lasting Inhibition of Platelet Aggregation Following a Relatively Short-Course Administration of n-3 Fatty Acid Ethyl Esters; A. M. Cerbone, T. Cusano, E. Tremoli, C. Galli, F. Cirillo, A. Coppola, E. Stragliotto, A. Amoriello, V. Marottoli, G. Vecchione, G. Di Minno. V: Diabetes. 19. Insulin Resistance and Cardiovascular Risk Factors in Noninsulin-Dependent Diabetes Mellitus; K. G. M. M. Alberti. 20. Glucose as a Risk Factor for Atherosclerosis; R. Bucala, A. Cerami. 21. Dyslipidemia in NIDDM: New Insights; M.-R. Taskinen, M. Syvänne, S. Lahdenperä. 22. Diabetes and Cardiovascular Risk: Epidemiological Aspects; S. M. Haffner. 23. Rational Treatment of the `Plurimetabolic Syndrome'; A. Tiengo, A. Avogaro, S. Del Prato. 24. Kidney Protection in Diabetes Mellitus; K. H. Rahn, M. Barenbrock, B. Suwelack, H. Hohage. 25. Association of Serum Uric Acid with Triglyceride Levels in Female Patients with NIDDM; W. Rathmann, H. Hauner, B. Haastert, K. Kirchner, F. A. Gries. 26. Cardiovascular Disease Prevention in the Elderly; G. Crepaldi, E. Manzato. VI: Diabetic Dyslipidemia and Atherosclerosis: Current Clinical Findings and Treatment Strategies. 27. Insulin Resistance and Coronary Heart Disease; G. M. Reaven. 28. Diabetic Dyslipidemia: The Asian Perspective; T.-Y. Tai, C.-J. Change, Y.-T. Lee. 29. Therapeutic Intervention in Diabetic Dyslipidemia; A. M. Gotto Jr. VII: Hypertension. 30. Red Blood Cell Cation Heteroexchange and Cardiovascular Risk; A. Semplicini, G. Ceolotto, M. Felice, A. Gebbin, A. Fontebasso, R. Valle, L. Serena, C. Dal Palù. 31. Hypertension in the Elderly with Special Focus on Side Effects; L. H. Lindholm. VIII: Therapeutic Interventions. 32. Drugs Directly Affecting the Arterial Wall; R. Paoletti, M. R. Soma. 33. The POSCH Trial: Importance of Cholesterol Lowering in Reducing Coronary Heart Disease Progression; C. T. Campos, H. Buchwald, the POSCH Group. 34. Three-Dimensional Reconstruction of Intracoronary Ultrasound Images: Technical Approaches, Clinical Applications, and Current Limitations in the Assessment of Vessel Dimensions; C. von Birgelen, C. Di Mario, W. Li, F. Prati, N. Bom, J. R. T. C. Roelandt, P. W. Serruys. IX: New Trends in the Use of Fibrates. 35. Metabolic Basis of the Atherogenic Lipoprotein Phenotype; C. J. Packard, J. Shepherd. 36. Fibrates: Modes of Action; A. L. Catapano. 37. Fenofibrate: A Safety Evaluation of a Large German Patient Population; K. U. Kirschgässler. X: New Insights on Cholesterol Controversy. 38. Plasma Cholesterol and Total Mortality; R. Paoletti, A. Poli. 39. Cholesterol-Lowering Coronary Angiography Trials: An Overview; L. J. Hirsch. 40. Treatment of Hyperlipidemia in Specific Types of Patients: The Elderly, Women, and Patients with Coronary Heart Disease; D. R. Illingworth. 41. An Italian Multicenter Study on the Efficacy and Tolerability of Simvastatin in Male Patients with Essential Hypertension and Primary Hypercholesterolemia; A. Salvetti, G. Argenio, G. Bernini. 42. Effects of Simvastatin Treatment on Thromboxane (TX) Biosynthesis and Platelet Function in Type II Hypercholesterolemia (HC); A. Notarbartolo. XI: Risk Factors. 43. Risk Factor Interactions Involving Pressor Agents; G. V. R. Born, L. E. Cardona-Sanclemente. 44. Hemodynamic and Adrenergic Effects of Cigarette Smoking; G. Grassi, A. Lanfranchi, S. Vailati, G. Seravalle, B. M. Cattaneo, G. Mancia. 45. Serum Uric Acid and 18-Year Cardiovascular Mortality in the Chicago Heart Association Detection Project in Industry; A. R. Dyer, R. Stamler, J. Stamler, D. Garside. 46. The Impact of High-Density Lipoprotein Cholesterol on Cardiovascular Risk: The Bezafibrate Infarction Prevention (BIP) Study; U. Goldbourt for the BIP Study Research Group. 47. Triglycerides and the Fibrinolytic System; E. Tremoli, L. Sironi, M. Camera, L. Mannucci, L. Prati, C. Banfi, D. Baldassare, L. Mussoni. 48. Apolipoprotein E and Alzheimer's Disease; G. Franceschini, L. Calabresi, C. R. Sirtori, G. B. Frisoni, C. Geroldi, A. Bianchetti, M. Trabucchi, S. Govoni. 49. Apolipoprotein A1: A Natural Kidney-Protective Agent? J. R. Paterniti, Jr., B. F. Burkey, D. France, H. Wong, X. Ma, B. Brand, C. Abuhani, M. R. Diffenderfer, J. B. Marsh, E. A. Fisher. XII: Vascular Reactivity and Remodeling. 50. Noninvasive Evaluation of Arterial Reactivity in Patients with Premature Onset Coronary Disease; P. Rubba, C. Sapio, P. Pauciullo, A. Iannuzzi, G. Iannuzzo, D. Iorio, N. Spampinato, M. Mancini. 51. Long-Chain Acylcarnitine as Membrane Stabilizer; W. C. Hülsmann, A. Peschechera. XIII: Protective Effects of Moderate Consumption of Alcohol on the Incidence of Coronary Heart Disease. 52. Protective Effects of Moderate Consumption of Alcohol on the Incidence of Coronary Heart Disease; M. H. Criqui. 53. Alcohol Consumption: Weighing the Cardiovascular Benefit with the Overall Health Risk; E. B. Rimm. 54. Alcohol and Atherosclerosis; A. Catapano. Index.

< to archive...